Send me a link:

*Text messaging rates may apply.

 Dow Down 0.42% Nasdaq Down 0.39%

Halozyme Therapeutics, Inc. (HALO)

-NasdaqGS
9.28 Down 0.46(4.72%) Aug 1, 4:00PM EDT
|After Hours : 9.28 0.00 (0.00%) Aug 1, 5:27PM EDT
Prev Close:9.74
Open:9.87
Bid:9.16 x 1000
Ask:9.48 x 200
1y Target Est:13.93
Beta:1.99
Earnings Date:Aug 4 - Aug 8 (Est.)
Day's Range:9.16 - 9.87
52wk Range:6.51 - 18.18
Volume:2,450,914
Avg Vol (3m):1,838,270
Market Cap:1.10B
P/E (ttm):N/A
EPS (ttm):-0.79
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for HALO

Comparison

Symbol% ChgMkt Cap
HALODown 4.72%1.10B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):21.09
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.60
Quarterly EPS Est (Jun-14) :-0.14
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Halozyme Therapeutics, Inc., a biopharmaceutical company, researches, develops, and commercializes human enzymes. Its research focuses on human enzymes that transiently modify tissue under the skin to facilitate the delivery of injected drugs and ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback